Q1 2021 Trinity Biotech PLC Earnings Call Transcript
Good day, and welcome to the Trinity Biotech First Quarter 2021 Financial Results Conference Call. (Operator Instructions) Please note, this event is being recorded.
I would now like to turn the conference over to Joe Diaz of Lytham Partners. Please go ahead.
Thank you, Betsy, and thanks to all of you for joining us today to review the financial results of Trinity Biotech for the first quarter of 2021, which ended on March 31, 2021.
Joining us on today's call is Ronan O'Caoimh, CEO of Trinity Biotech; and John Gillard, CFO. At the conclusion of today's prepared remarks, we will open the call for a question-and-answer session.
Please be aware that statements made in the course of this earnings call may be deemed forward-looking statements within the meaning of federal securities laws. These statements are subject to known and unknown risks and uncertainties that may cause actual results to differ from those expressed or implied in such statements. These risks include, but are not
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |